# Panchsheel Org (NSE: PANCHSHEEL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/PANCHSHEEL · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹159 Cr, it ranks 2411th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was 10.3% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹31 Cr (+9.5% year on year) and net profit ₹2 Cr (−46.4%), on a standalone basis. Promoters held 56.12% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹159 Cr |
| ROE | 10.3% (FY25) |
| ROCE | 13.3% (FY25) |
| Debt to equity | 0.04 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹31 Cr | +9.5% | ₹2 Cr | −46.4% | ₹1.29 |
| Q3 FY26 | ₹27 Cr | +1.9% | ₹4 Cr | +0.3% | ₹2.79 |
| Q2 FY26 | ₹25 Cr | −6.8% | ₹3 Cr | −31.1% | ₹1.98 |
| Q1 FY26 | ₹24 Cr | −9.6% | ₹3 Cr | −16.9% | ₹2.16 |
| Q4 FY25 | ₹28 Cr | −9.3% | ₹3 Cr | +14.0% | ₹2.41 |
| Q3 FY25 | ₹26 Cr | +2.5% | ₹4 Cr | −13.8% | ₹2.79 |
| Q2 FY25 | ₹27 Cr | +14.6% | ₹4 Cr | +2.7% | ₹2.88 |
| Q1 FY25 | ₹26 Cr | +5.8% | ₹3 Cr | +1.2% | ₹2.60 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹107 Cr | ₹14 Cr |
| FY24 | ₹105 Cr | ₹14 Cr |
| FY23 | ₹103 Cr | ₹14 Cr |
| FY22 | ₹69 Cr | ₹8 Cr |
| FY21 | ₹49 Cr | ₹5 Cr |
| FY20 | ₹51 Cr | ₹5 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 56.12%
- Non-institutions: 43.88%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Take Solutions](https://app.pivotnow.in/stock/TAKE) | ₹11.96 | ₹177 Cr | 41.2 | — |
| [Bal Pharma](https://app.pivotnow.in/stock/BALPHARMA) | ₹109.58 | ₹174 Cr | 27.7 | — |
| [Vaidya Sane Ayu](https://app.pivotnow.in/stock/MADHAVBAUG) | ₹161.10 | ₹169 Cr | — | — |
| [Natural Capsules](https://app.pivotnow.in/stock/NATCAPSUQ) | ₹162.00 | ₹169 Cr | — | — |
| [Auro Labs](https://app.pivotnow.in/stock/AUROLAB) | — | ₹156 Cr | — | — |
| [Kimia Bio](https://app.pivotnow.in/stock/KIMIABL) | — | ₹152 Cr | — | — |

## Questions and answers

### What is the market cap of Panchsheel Org?

Panchsheel Org's market capitalisation is ₹159 Cr (₹159 Cr) at the 19 Oct 2026 close, ranking 2411th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Panchsheel Org?

Return on equity was 10.3% in FY25 and return on capital employed was 13.3% in FY25 (standalone figures).

### Is Panchsheel Org a debt-free company?

Panchsheel Org is close to debt-free: its debt-to-equity ratio was 0.04 in FY25.

### What were Panchsheel Org's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Panchsheel Org reported revenue of ₹31 Cr, +9.5% year on year, and net profit of ₹2 Cr, −46.4% year on year.

### What is the shareholding pattern of Panchsheel Org?

As of 30 Jun 2026: promoters 56.12%, non-institutions 43.88%.

### Who are Panchsheel Org's competitors?

The listed Pharma & Healthcare companies closest to Panchsheel Org by market cap are Take Solutions, Bal Pharma, Vaidya Sane Ayu, Natural Capsules, Auro Labs and Kimia Bio.

### Is Panchsheel Org a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Panchsheel Org's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PANCHSHEEL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.